| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/02/2006 | CA2578283A1 Heterocyclic compounds and methods of use |
| 03/02/2006 | CA2578021A1 Modified human hepatitis c virus genomic rna that can be autonomously replicated |
| 03/02/2006 | CA2577926A1 Nutritional composition comprising immunoglobulins and oligosaccharides |
| 03/02/2006 | CA2577528A1 Heterocyclic antiviral compounds |
| 03/02/2006 | CA2577526A1 Antiviral 4'-azido-nucleosides |
| 03/02/2006 | CA2577191A1 4-heteroarylmethyl substituted phthalazinone derivatives |
| 03/02/2006 | CA2576562A1 Nutritional composition comprising galactose-containing indigestible oligosaccharides |
| 03/02/2006 | CA2576247A1 Pharmaceutical compositions comprising inhibitors of iron transport, and method of identifying iron transport inhibitors, in staphylococcus aureus |
| 03/02/2006 | CA2574516A1 Vaccine composition against rhodococcus equi |
| 03/02/2006 | CA2571132A1 Novel compounds having an anti-bacterial activity |
| 03/01/2006 | EP1630230A2 Streptococcus pneumoniae proteins and nucleic acids |
| 03/01/2006 | EP1630172A2 A method for identification, isolation and production of antigens to a specific phathogen |
| 03/01/2006 | EP1630168A2 Molecular mimetics of meningococcal B peptides |
| 03/01/2006 | EP1630160A1 The isoflavone derivatives of tectoridin, the preparation thereof and the anti-virus medicines containing the same as the effective constituents |
| 03/01/2006 | EP1629850A1 Nutritional composition comprising indigestible oligosaccharides |
| 03/01/2006 | EP1629846A2 Topical use of probiotic bacillus spores to prevent or control microbial infections |
| 03/01/2006 | EP1629842A1 Topical application of thiazolyl amides |
| 03/01/2006 | EP1629838A1 Footcare product with glycerin and no added water |
| 03/01/2006 | EP1629091A2 Compound containing polyprotein ns3/ns4 and hcv polypeptide ns5b, expression vectors comprising corresponding nucleic sequences and the therapeutic application thereof |
| 03/01/2006 | EP1629009A1 Compositions comprising large and small binding fragments of antibodies against the same toxin |
| 03/01/2006 | EP1629000A2 Macrocyclic isoquinoline peptide inhibitors of hepatitis c virus |
| 03/01/2006 | EP1628994A2 Method for identifying modulators of g protein coupled receptor signaling |
| 03/01/2006 | EP1628683A2 Vaccine composition comprising iron phosphate as a pharmaceutical aid to said vaccine |
| 03/01/2006 | EP1628655A2 Antiseptic compositions, methods and systems |
| 03/01/2006 | EP1628646A2 Use of ppar-gamma agonists as anti-infective agents |
| 03/01/2006 | EP1628530A2 Methods and compositions for the prevention and treatment of sepsis |
| 03/01/2006 | EP1389234B1 Cd8alpha + lymphoid dendritic cell differentiated from human hematopoietic stem cell and a method for differentiation |
| 03/01/2006 | EP1363910B1 Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors |
| 03/01/2006 | EP1343790B1 Cephalosporin production |
| 03/01/2006 | EP1324774B1 Use of a ppar delta activator for treating inflammatory conditions |
| 03/01/2006 | EP1311672B1 tRNA-derived inhibitors of HIV reverse transcriptase |
| 03/01/2006 | EP1311507B1 Fused pyrazole derivatives being protein kinase inhibitors |
| 03/01/2006 | EP1233962B1 Novel heterocyclic compounds and their use as medicines |
| 03/01/2006 | EP1185948B1 Method for screening and producing compound libraries |
| 03/01/2006 | EP1169465B1 Two-step immunization procedure against chlamydia infection |
| 03/01/2006 | EP1092035B1 Targeted integration into chromosomes using retroviral vectors |
| 03/01/2006 | EP1049488B1 Method of and compositions for immunization with the pseudomonas aeruginosa v-antigen |
| 03/01/2006 | EP1038001B1 Constitutive expression of non-infectious hiv-like particles |
| 03/01/2006 | EP0914346B1 THERAPEUTIC MULTISPECIFIC COMPOUNDS COMPRISED OF ANTI-FCalpha RECEPTOR ANTIBODIES |
| 03/01/2006 | EP0862634B2 Pharmaceutical composition for treating papillomavirus tumours and infection |
| 03/01/2006 | EP0750507B2 Proteasome regulation of nf-kappa-b activity |
| 03/01/2006 | CN1742018A Antiviral nucleoside derivatives |
| 03/01/2006 | CN1742015A Oxazolidinone and / or isoxazoline derivatives as antibacterial agents |
| 03/01/2006 | CN1742008A Antibacterial indolone oxazolidinones, intermediates for their preparation and pharmaceutical compositions containing them |
| 03/01/2006 | CN1741820A Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 03/01/2006 | CN1741819A Sustained release composition for oral administration of drugs |
| 03/01/2006 | CN1740197A Recombination interferon with new space conformation and enhanced effect, its preparing method and application |
| 03/01/2006 | CN1740179A N4-substituent pyrazolyl [4,5-e][1,2,4] thiadiazine derivative and its prepn process and medicine composition |
| 03/01/2006 | CN1740175A Plumepoppy total alkaloid salt and its prepn and application |
| 03/01/2006 | CN1740172A Abacavin preparing process |
| 03/01/2006 | CN1740170A Prepn process of peptide HIV proteinase inhibitor |
| 03/01/2006 | CN1739802A Method of producing hepatitis B vaccine in non-human mammal mammary gland as bioreactor |
| 03/01/2006 | CN1739801A Influenza virus lysis vaccine and its prepn process |
| 03/01/2006 | CN1739800A Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
| 03/01/2006 | CN1739794A Thymosin alpha-1 aqua prepn and its prepn process and application |
| 03/01/2006 | CN1739787A Orally administered peptides to ameliorate atherosclerosis |
| 03/01/2006 | CN1739786A Thymic pentapeptide aqua prepn and its prepn process and application |
| 03/01/2006 | CN1739780A Miao medicine for treating tuberculosis and rheumatic heart disease and its compounding process and usage |
| 03/01/2006 | CN1739754A Lotion for treating mycotic vaginitis |
| 03/01/2006 | CN1739748A Cold treating medicine and its prepn |
| 03/01/2006 | CN1739737A Chinese medicine powder for treating tuberculosis and its usage |
| 03/01/2006 | CN1739732A Compound Chuanhuning prepn and its prepn process |
| 03/01/2006 | CN1739719A Dermatosis treating Chinese medicine prepn |
| 03/01/2006 | CN1739686A Chinese medicine injection for clearing away heat and toxic matter and its prepn process |
| 03/01/2006 | CN1739685A Compound isatis leaf-vitamin C prepn |
| 03/01/2006 | CN1739682A Nudiflorous beautyberry soft capsule for body cavity and its prepn |
| 03/01/2006 | CN1739668A Transaminase lowering dripping pill and its prepn |
| 03/01/2006 | CN1739650A Cappillary artemisia-cape jasmine-rhubarb soft capsule and its prepn process |
| 03/01/2006 | CN1739647A Zoster treating ointment and its prepn |
| 03/01/2006 | CN1739625A AIDS treating medicine |
| 03/01/2006 | CN1739602A Technological process of extracting effective hepatitis resisting component from Halenia comiculata plant |
| 03/01/2006 | CN1739597A Cajan seed extract with herpesvirus resisting activity |
| 03/01/2006 | CN1739596A Recipe and prepn of injection containing volatile honeysuckle oil |
| 03/01/2006 | CN1739538A Suppository for teating mycotic vaginitis |
| 03/01/2006 | CN1739536A Compound prepn containing monopotassium glycyrrhizunate and its prepn and application |
| 03/01/2006 | CN1739526A Prepn process of oral slowly-releasing oleanolic acid |
| 03/01/2006 | CN1739519A Itraconazole emulsion for injection and its prepn |
| 03/01/2006 | CN1739511A Application of penehyliclidine hydrochloride in preparing medicine |
| 03/01/2006 | CN1739507A Medicine composition for treating mixed infectious disease |
| 03/01/2006 | CN1739505A L-ornidazole injection prepn |
| 03/01/2006 | CN1739504A L-ornidazole prepn |
| 03/01/2006 | CN1243828C RNA adaptor capable of restraining typhoid bacilli from invading to cells of human body, and preparation method |
| 03/01/2006 | CN1243767C Immunomodulatory steroids, in particular hemihydrate of 16 alpha-bromoepiandrosterone |
| 03/01/2006 | CN1243766C -’툷Á€-9-�ÐЧ-9A-Á¬ÈË-9A-©›‘ýå˜öÏAÐœ•·Ü´ |
| 03/01/2006 | CN1243764C Dieneacetal peroxide glycoside kind derivative and its preparation method and its medicinal composition and use |
| 03/01/2006 | CN1243724C Amide derivatives which are useful as cell factor inhibitors |
| 03/01/2006 | CN1243568C Recombination protein for preventing human trachoma bedsnia infestation and its use |
| 03/01/2006 | CN1243551C Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response |
| 03/01/2006 | CN1243545C DNA-cleaving antitumor agents |
| 02/28/2006 | US7005438 Pharmaceutically active isoindoline derivatives |
| 02/28/2006 | US7005433 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 02/28/2006 | US7005417 Echinocandin derivatives, method for preparing same and use as antifungal agents |
| 02/28/2006 | US7005416 Synergistic; treating grampositive and gramnegative bacterial infections, kits |
| 02/28/2006 | US7005408 Anhydrous warming, non- toxic and nonirritating lubricating compositions containing polyhydric alcohols and an insulating agent. The invention also relates to methods of using such compositions for lubrication, administration of active |
| 02/28/2006 | US7005255 Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
| 02/28/2006 | US7005129 Non-toxic mutants of pathogenic gram-negative bacteria |
| 02/28/2006 | US7005122 Delivery of sumatriptan, frovatriptan or naratriptan through an inhalation route |
| 02/28/2006 | US7005121 Arerosol; heating drug, vaporization, cooling |
| 02/28/2006 | CA2373117C 13-methyl-erythromycin derivatives |
| 02/28/2006 | CA2180346C Herpesvirus pre-(viral dna replication) enveloped particles |